centrally acting agents due to lack of direct studies of relevance in OA. Tramadol is conditionally recommended for patients with knee, hip, and/or OA. Recent work has highlighted the very modest level of beneficial effects in the long-term (3 months to 1 year) management of non-cancer pain with opioids Non-tramadol opioids are conditionally recommended against in patients with knee, hand, and/or hip OA with the recognition that they may be used under certain circumstances, particularly when